Drug Approval | April 17, 2026
Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Subscribe To Our Newsletter & Stay Updated
